Publication | Open Access

Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells

Cancer ImmunosurveillanceMedicineImmunologyImmunoeditingImmunologic MechanismLeukemia CellsCytotoxic ActivityImmunotherapyNk CellsCell Biology